Tatjana Naranda
Präsident bei ALEXZA PHARMACEUTICALS, INC.
Ursprung des Netzwerks ersten Grades von Tatjana Naranda
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 40 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Tatjana Naranda
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
SurroMed, Inc.
 SurroMed, Inc. Miscellaneous Commercial ServicesCommercial Services SurroMed, Inc. provides pharmaceutical research. It focuses on discovering & applying biomarkers to improve the drug discovery and development process and enable the precise diagnosis and personalized treatment of disease. The company's research process yields biological markers and information that enable accelerated, cost-efficient discovery and development of new therapeutic products, as well as development of diagnostic tests for early disease detection, disease staging, patient stratification, guiding and monitoring therapy. SurroMed was founded in 1997 and is located in Menlo Park, CA. | Miscellaneous Commercial Services | Founder Chief Executive Officer Founder | |
| AFFYMAX, INC. | Biotechnology | Director of Finance/CFO Founder Corporate Officer/Principal | |
| ALZA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Founder Corporate Officer/Principal | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Founder | |
| Stanford University | College/University | Director/Board Member Masters Business Admin Masters Business Admin | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| VIVUS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director of Finance/CFO | |
Orphan Medical, Inc.
 Orphan Medical, Inc. Pharmaceuticals: MajorHealth Technology Orphan Medical, Inc. develops and markets pharmaceutical and health care products. The company was founded in 1993 and is located in Minnetonka, MN. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| San Jose State University | College/University | Undergraduate Degree Graduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Colorado | College/University | Graduate Degree Undergraduate Degree | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of California, San Francisco | College/University | Doctorate Degree Corporate Officer/Principal | |
| ACHIEVE LIFE SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree | |
Alavita Pharmaceuticals, Inc.
 Alavita Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alavita Pharmaceuticals, Inc. develops pharmaceutical therapeutic products. The company was founded on October 9, 2007 and is headquartered in Los Altos, CA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| 4D MOLECULAR THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| CORCEPT THERAPEUTICS INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| Colgate University | College/University | Undergraduate Degree Undergraduate Degree | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company was founded on April 15, 1992 and is headquartered in Mountain View, CA. | Biotechnology | Corporate Officer/Principal Chief Executive Officer | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| CALITHERA BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| San Francisco Conservatory of Music | College/University | Director/Board Member | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| Delphi Management Partners VIII LLC | Corporate Officer/Principal | ||
| University of London | College/University | Doctorate Degree | |
| University of Sunderland | College/University | Undergraduate Degree | |
| CATALENT PHARMA SOLUTIONS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistik
International
| Vereinigte Staaten | 44 |
| Vereinigtes Königreich | 6 |
| Kanada | 3 |
Sektoral
| Health Technology | 31 |
| Consumer Services | 11 |
| Commercial Services | 7 |
| Finance | 3 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 198 |
| Corporate Officer/Principal | 100 |
| Independent Dir/Board Member | 64 |
| Chief Tech/Sci/R&D Officer | 34 |
| Undergraduate Degree | 33 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Ernest Mario | 44 |
| Deepa Pakianathan | 32 |
| Samuel D. Colella | 31 |
| Alan Frazier | 31 |
| J. Read | 27 |
| J. Buchi | 26 |
| Joseph Turner | 22 |
| Gordon Ringold | 20 |
| Anthony Clarke | 17 |
| Thomas King | 16 |
| Hal Barron | 16 |
| Isaac Stein | 15 |
| Christopher Kurtz | 14 |
| Robert Fishman | 11 |
| August Moretti | 10 |
- Börse
- Insiders
- Tatjana Naranda
- Unternehmensverbindungen
